Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IDEAYA Biosciences (IDYA) Retained Earnings (2019 - 2025)

Historic Retained Earnings for IDEAYA Biosciences (IDYA) over the last 7 years, with Q4 2025 value amounting to -$736.5 million.

  • IDEAYA Biosciences' Retained Earnings fell 1825.47% to -$736.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$736.5 million, marking a year-over-year decrease of 1825.47%. This contributed to the annual value of -$736.5 million for FY2025, which is 1825.47% down from last year.
  • As of Q4 2025, IDEAYA Biosciences' Retained Earnings stood at -$736.5 million, which was down 1825.47% from -$653.3 million recorded in Q3 2025.
  • Over the past 5 years, IDEAYA Biosciences' Retained Earnings peaked at -$136.0 million during Q1 2021, and registered a low of -$772.5 million during Q2 2025.
  • Over the past 5 years, IDEAYA Biosciences' median Retained Earnings value was -$300.7 million (recorded in 2023), while the average stood at -$373.9 million.
  • Data for IDEAYA Biosciences' Retained Earnings shows a peak YoY increase of 1825.47% (in 2025) and a maximum YoY decrease of 7915.82% (in 2025) over the last 5 years.
  • Over the past 5 years, IDEAYA Biosciences' Retained Earnings (Quarter) stood at -$176.7 million in 2021, then tumbled by 33.19% to -$235.4 million in 2022, then plummeted by 47.99% to -$348.4 million in 2023, then tumbled by 78.79% to -$622.8 million in 2024, then fell by 18.25% to -$736.5 million in 2025.
  • Its Retained Earnings stands at -$736.5 million for Q4 2025, versus -$653.3 million for Q3 2025 and -$772.5 million for Q2 2025.